# Copper Property CTL Pass Through Trust: financial statements, quarterly

CPPTL · OTC · CIK 1837671 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/cpptl.md) · [Financials](/companies/cpptl/financials.md) · [Filings](/companies/cpptl/filings.md) · [Insiders](/companies/cpptl/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/cpptl/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net income | $m | [19.7](/filings/0001837671-24-000054.md) | [15.5 d](/filings/0001837671-26-000019.md) | [17.8](/filings/0001837671-25-000022.md) | [17.9](/filings/0001837671-25-000048.md) | [16.4](/filings/0001837671-25-000080.md) | [21.7 d](/filings/0001837671-26-000019.md) | [16.1](/filings/0001837671-26-000034.md) | [22.2](/filings/0001837671-26-000063.md) | [1.3](/filings/0001837671-25-000080.md) | [7.5 d](/filings/0001837671-26-000019.md) | [11.5](/filings/0001837671-26-000034.md) | [14.7](/filings/0001837671-26-000063.md) |
| Diluted EPS | $ per share | [0.26](/filings/0001837671-24-000054.md) | not reported | [0.24](/filings/0001837671-25-000022.md) | [0.24](/filings/0001837671-25-000048.md) | [0.22](/filings/0001837671-25-000080.md) | not reported | [0.21](/filings/0001837671-26-000034.md) | [0.30](/filings/0001837671-26-000063.md) | [0.02](/filings/0001837671-25-000080.md) | not reported | [0.15](/filings/0001837671-26-000034.md) | [0.20](/filings/0001837671-26-000063.md) |
| Basic EPS | $ per share | [0.26](/filings/0001837671-24-000054.md) | not reported | [0.24](/filings/0001837671-25-000022.md) | [0.24](/filings/0001837671-25-000048.md) | [0.22](/filings/0001837671-25-000080.md) | not reported | [0.21](/filings/0001837671-26-000034.md) | [0.30](/filings/0001837671-26-000063.md) | [0.02](/filings/0001837671-25-000080.md) | not reported | [0.15](/filings/0001837671-26-000034.md) | [0.20](/filings/0001837671-26-000063.md) |

- Interest expense: not reported
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [33.9](/filings/0001837671-23-000072.md) | [38.0](/filings/0001837671-25-000011.md) | [49.8](/filings/0001837671-24-000028.md) | [47.0](/filings/0001837671-24-000043.md) | [46.1](/filings/0001837671-24-000054.md) | [51.9](/filings/0001837671-26-000019.md) | [34.0](/filings/0001837671-25-000022.md) | [35.0](/filings/0001837671-25-000048.md) | [48.9](/filings/0001837671-25-000080.md) | [37.1](/filings/0001837671-26-000063.md) | [34.0](/filings/0001837671-26-000034.md) | [35.0](/filings/0001837671-26-000063.md) |
| Total assets | $m | [1,245](/filings/0001837671-23-000072.md) | [1,234](/filings/0001837671-25-000011.md) | [1,221](/filings/0001837671-24-000028.md) | [1,197](/filings/0001837671-24-000043.md) | [1,176](/filings/0001837671-24-000054.md) | [1,136](/filings/0001837671-26-000019.md) | [1,114](/filings/0001837671-25-000022.md) | [1,091](/filings/0001837671-25-000048.md) | [1,074](/filings/0001837671-25-000080.md) | [1,049](/filings/0001837671-26-000063.md) | [1,040](/filings/0001837671-26-000034.md) | [1,034](/filings/0001837671-26-000063.md) |
| Total liabilities | $m | [143](/filings/0001837671-23-000072.md) | [141](/filings/0001837671-25-000011.md) | [136](/filings/0001837671-24-000028.md) | [133](/filings/0001837671-24-000043.md) | [132](/filings/0001837671-24-000054.md) | [122](/filings/0001837671-26-000019.md) | [121](/filings/0001837671-25-000022.md) | [118](/filings/0001837671-25-000048.md) | [120](/filings/0001837671-25-000080.md) | [116](/filings/0001837671-26-000063.md) | [115](/filings/0001837671-26-000034.md) | [114](/filings/0001837671-26-000063.md) |
| Shareholders' equity | $m | [1,102](/filings/0001837671-24-000054.md) | [1,094](/filings/0001837671-26-000019.md) | [1,085](/filings/0001837671-25-000048.md) | [1,064](/filings/0001837671-25-000080.md) | [1,044](/filings/0001837671-25-000080.md) | [1,014](/filings/0001837671-26-000063.md) | [992](/filings/0001837671-26-000063.md) | [974](/filings/0001837671-26-000063.md) | [955](/filings/0001837671-25-000080.md) | [933](/filings/0001837671-26-000063.md) | [925](/filings/0001837671-26-000063.md) | [920](/filings/0001837671-26-000063.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [23.4 d](/filings/0001837671-24-000054.md) | [23.1 d](/filings/0001837671-26-000019.md) | [22.0](/filings/0001837671-25-000022.md) | [23.3 d](/filings/0001837671-25-000048.md) | [23.3 d](/filings/0001837671-25-000080.md) | [23.6 d](/filings/0001837671-26-000019.md) | [19.9](/filings/0001837671-26-000034.md) | [21.6 d](/filings/0001837671-26-000063.md) | [19.7 d](/filings/0001837671-25-000080.md) | [18.1 d](/filings/0001837671-26-000019.md) | [16.2](/filings/0001837671-26-000034.md) | [20.4 d](/filings/0001837671-26-000063.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [75.0](/filings/0001837671-23-000072.md) | [75.0](/filings/0001837671-24-000028.md) | [75.0](/filings/0001837671-24-000043.md) | [75.0](/filings/0001837671-24-000054.md) | [75.0](/filings/0001837671-25-000022.md) | [75.0](/filings/0001837671-25-000048.md) | [75.0](/filings/0001837671-25-000080.md) | [75.0](/filings/0001837671-26-000034.md) | [75.0](/filings/0001837671-26-000063.md) | [75.0](/filings/0001837671-25-000080.md) | [75.0](/filings/0001837671-26-000034.md) | [75.0](/filings/0001837671-26-000063.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 0 at 2026-06-30, from the cover of the [10-Q filed 2026-08-14](/filings/0001837671-26-000063.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. No prices; not investment advice.